Government Funding

Canadian federal health research funder with direct psilocybin psychotherapy trial grants.

U.S. Department of Defense biomedical funding office administering congressionally appropriated research awards, including FY24 psychedelic treatment clinical trial funding under DMRDP.

US defense research funder with psychedelic-informed neuropsychiatric R&D (Focused Pharma).

EU supranational research funding framework supporting psilocybin clinical research (PsyPal).

French National Institute of Health and Medical Research (INSERM), a national public biomedical research organization with active discourse and research engagement on psychedelic medicine.

Australian Government medical research funder with explicit psychedelic trial grants (including ketamine, psilocybin, and MDMA).

NIH institute funding psychedelic oncology-adjacent mental health research, including psilocybin therapy studies for advanced cancer-related distress.

NIH institute funding psychedelic clinical research, including psilocybin-assisted psychotherapy protocols in depression and chronic pain populations.

UK public health research funder with NIHR-backed psilocybin addiction trial funding.

NIH institute with active psilocybin-related project awards in depression and neuroscience.

NIH institute funding neuroscience projects involving psychedelics, including psilocybin-related chronic pain and neuroplasticity investigations.

NIH institute with co-funded psychedelic research activity, including projects on psychedelics for older adults with chronic pain.

NIH institute funding psychedelic-related alcohol use disorder research, including psilocybin-assisted treatment and derivative development projects.

NIH institute with active psilocybin-related project awards in addiction-focused portfolios.

The state public health agency for Texas, responsible for promoting and protecting the health of Texans through disease prevention, health promotion, and oversight of public health services. The agency licenses healthcare facilities, monitors communicable diseases, and supports mental health and substance use programs.

Texas state health agency administering ibogaine clinical trial grant funding authorized by SB 2308 and overseeing a large public-private research initiative.

U.S. Army medical R&D command supporting military biomedical research and administration pathways connected to DoD psychedelic clinical trial funding.

Federal veterans health system funding psychedelic-assisted therapy research, including VA-funded MDMA studies and related opportunities.

Federal defense department overseeing military health R&D and psychedelic-related clinical trial funding via DHA/DMRDP implementation.

Naval Medical Center San Diego (NMCSD) is the US Navy’s largest hospital on the West Coast, providing medical care to active-duty military personnel, retirees, and their families. Its Department of Psychiatry participates in clinical trials investigating MDMA-assisted and psilocybin-assisted therapies for PTSD and depression in service members, contributing to the DoD’s expanding psychedelic research program.

The VA Connecticut Healthcare System provides comprehensive medical and mental health services to veterans across Connecticut, with campuses in West Haven and Newington. As part of the VA's expanding psychedelic research program, it participates in clinical trials investigating MDMA-assisted therapy and psilocybin for PTSD and related conditions affecting veterans.

The VA Puget Sound Health Care System serves veterans across the Pacific Northwest with major facilities in Seattle and Tacoma, Washington. As part of the VA’s expanding psychedelic research program, it participates in clinical trials examining MDMA-assisted therapy and psilocybin for PTSD and depression in veterans.

Vancouver Island Health Authority (Island Health) is a publicly funded regional health authority serving Vancouver Island and surrounding communities in British Columbia, Canada. Island Health operates hospitals, mental health services, and community health programs for over 800,000 residents, and supports clinical research including innovative approaches to psychedelic-assisted mental health treatment.

Västra Götalandsregionen (Region Västra Götaland) is the regional government and public health authority for western Sweden, including the Gothenburg metropolitan area and surrounding counties. With 1.7 million residents served by 17 hospitals and over 50,000 employees, it is one of Sweden's largest public employers and a major supporter of clinical psychiatric research.

Walter Reed National Military Medical Center (WRNMMC) is the United States' premier military medical center, located in Bethesda, Maryland and operated jointly by the Army and Navy. It provides advanced medical care to active duty service members, veterans, retirees, and their families, and conducts clinical research on PTSD, traumatic brain injury, and emerging treatments for military personnel.

The World Health Organization (WHO) is the United Nations' specialized agency for international public health, founded in 1948 and headquartered in Geneva, Switzerland. WHO sets global health standards, coordinates disease surveillance, and provides technical guidance on mental health, substance use disorders, and the international scheduling of controlled substances including psychedelics.

ZonMw (The Netherlands Organisation for Health Research and Development) is a Dutch government organization that funds and steers health research and healthcare innovation on behalf of the Ministry of Health, Welfare and Sport and the Dutch Research Council (NWO). ZonMw finances studies across all healthcare domains including mental health, substance use disorders, and novel therapeutic approaches such as psychedelic-assisted therapy.